Background: Since 2009, breast cancer patients at the Cleveland Clinic have been offered Survivorship Visits during which treatment summaries and follow-up care plans are provided following a detailed assessment of patient reported concerns. Timing of the initial Survivorship Visit varied from within 6 months of to more than 5 years from completing initial therapy. It is hypothesized that survivorship needs will differ between early, middle and late survivorship periods. Methods: Through an IRB approved data base, we evaluated symptom prevalence among women treated for stage 0 to III breast cancer according to treatment received and by time interval between completion of initial treatment and the first formal Survivorship Visit. Time intervals were divided into early (within 6 months), middle (more than 6 months but less than 5 years) or late (5 years or more) survivorship periods with respect to completion date of local therapy and any chemotherapy. Symptom prevalence was compared among the three time intervals using the Chi-square test. Results: Between April 2009 and August 2015, 1257 patients received formal initial Survivorship Visits with completion of a survivorship questionnaire. Detailed results of patient reported rates of fatigue, pain, numbness, concentration difficulty, anxiety, depression, hot flashes, insomnia and sexual problems will be described during the three different survivorship periods (early, middle , and late). Conclusions: Understanding of patient reported concerns at various time points during cancer survivorship should allow for better tailoring of survivorship needs and services.